Admin

miCure Therapeutic secured a two million dollar seed investment from private investors

miCure Therapeutic secured a two million dollar seed investment from private investors

miCure Therapeutics is a leading-edge biotech company established in September 2013 in the Science Park of Ness Ziona, Israel. The company is focused on micro-RNA therapeutics and diagnostics for the central nervous system. miCure obtained an exclusive worldwide license from Yeda Research & Development Company Ltd. to develop products based on technologies emanating from the […]

miCure Therapeutics went through 3 capital raising rounds backed by private investors to progress the development of microRNA based therapy for depression

miCure Therapeutics went through 3 capital raising rounds backed by private investors to progress the development of microRNA based therapy for depression

miCure Therapeutics acquired key oligonucleodites patents fron nLife Therapeutics

miCure Therapeutics acquired key oligonucleodites patents fron nLife Therapeutics

miCure Therapeutics is a leading-edge biotech company focused on micro-RNA therapeutics and diagnostics for the central nervous system. Current development program based on mir135 mimic as a therapeutic agent for a long term management of Treatment Resistant Depressive patients (TRD patients). Oligonucleotide delivery solutions developed by nLife Therapeutics reinforces this program by reducing the effective […]